Bio-link Australia Pty. Ltd.

22nd September 2014 – Deal Facilitated between Children’s Cancer Institute and Abcam

Bio-Link has facilitated a global, exclusive licence, supply and distribution agreement for multidrug resistance protein 4 (MRP4/ABCC4) inhibitors, Ceefourin™ 1 and Ceefourin™ 2, for research purposes, between Children’s Cancer Institute and Abcam plc. Click here for the full press release.

cci-abcam